Maybe. How would you differentiate between a shareholder who has held 500,000 shares for 5 years compared to a shareholder who has held 100,000 for 15 years?
You can't really, that's why the above calculation of the SPP was fair.
Remember with SPP's the important number is the total number of shares APPLIED FOR as all qualifying shareholders will 'usually' be offered share 'parcels' ranging for $1,000 up to $20,000 or $30,000.
Assuming the $2mil limit is exceeded, scaleback of each holders application will have to occur (unless the company decides to expand the SPP) with the company returning excess funds back to holders.
You could have any number of 'qualifications' for 'scaleback' - the above was a relatively simple one and it worked although, as in all situations like this, there were complaints from some holders, particularly those who had recently sold heads.
GLTAH.
- Forums
- ASX - By Stock
- Ann: Successful Placement of $40.8M to Fund Future Growth
Maybe. How would you differentiate between a shareholder who has...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DYL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.62 |
Change
0.045(2.87%) |
Mkt cap ! $1.565B |
Open | High | Low | Value | Volume |
$1.61 | $1.64 | $1.58 | $8.475M | 5.251M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1235 | $1.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.63 | 4964 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2638 | 1.695 |
1 | 1201 | 1.665 |
1 | 100 | 1.660 |
2 | 7188 | 1.655 |
2 | 22500 | 1.640 |
Price($) | Vol. | No. |
---|---|---|
1.565 | 2907 | 1 |
1.600 | 20516 | 2 |
1.610 | 17116 | 2 |
1.615 | 3542 | 1 |
1.620 | 45512 | 3 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.63 |
  |
Change
0.045 ( 4.16 %) |
|||
Open | High | Low | Volume | ||
$1.61 | $1.64 | $1.58 | 1518808 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
DYL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online